These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9839514)

  • 1. Proton therapy faces high hurdles to general use.
    Castellucci L
    J Natl Cancer Inst; 1998 Dec; 90(23):1768-9. PubMed ID: 9839514
    [No Abstract]   [Full Text] [Related]  

  • 2. Proton therapy in an era of cost containment.
    Herman JM
    J Natl Compr Canc Netw; 2011 Aug; 9(8):821-5. PubMed ID: 21900217
    [No Abstract]   [Full Text] [Related]  

  • 3. "Proton therapy in an era of cost containment".
    Schulz RJ; Kagan AR
    J Natl Compr Canc Netw; 2012 Jan; 10(1):1. PubMed ID: 22223862
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost-effectiveness studies in radiation therapy.
    Sher DJ
    Expert Rev Pharmacoecon Outcomes Res; 2010 Oct; 10(5):567-82. PubMed ID: 20950072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton therapy: expanding clinical indications.
    Jones B; Price P
    Clin Oncol (R Coll Radiol); 2004 Aug; 16(5):324-5. PubMed ID: 15341434
    [No Abstract]   [Full Text] [Related]  

  • 6. The promise of protons in cancer therapy.
    Macready N
    J Natl Cancer Inst; 2012 May; 104(9):648-9. PubMed ID: 22517986
    [No Abstract]   [Full Text] [Related]  

  • 7. Radiotherapy: effective treatment at low cost!
    Read G
    Clin Oncol (R Coll Radiol); 1995; 7(5):275-6. PubMed ID: 8580050
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost effectiveness of proton versus photon radiation therapy with respect to the risk of growth hormone deficiency in children.
    Mailhot Vega R; Kim J; Hollander A; Hattangadi-Gluth J; Michalski J; Tarbell NJ; Yock TI; Bussiere M; MacDonald SM
    Cancer; 2015 May; 121(10):1694-702. PubMed ID: 25641407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No holding back. Report unlikely to slow demand for proton therapy.
    Rhea S
    Mod Healthc; 2009 Sep; 39(38):12. PubMed ID: 19810231
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of novel radiotherapy technologies: what evidence is needed to assess their clinical and cost effectiveness, and how should we get it?
    van Loon J; Grutters J; Macbeth F
    Lancet Oncol; 2012 Apr; 13(4):e169-77. PubMed ID: 22469127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arrests reveal debate about costs and benefits of proton therapy.
    Keener AB
    Nat Med; 2014 Oct; 20(10):1081. PubMed ID: 25295925
    [No Abstract]   [Full Text] [Related]  

  • 12. Dosimetric promise versus cost: critics question proton therapy.
    Furlow B
    Lancet Oncol; 2013 Aug; 14(9):805-6. PubMed ID: 24058960
    [No Abstract]   [Full Text] [Related]  

  • 13. Proton therapy of cancer: potential clinical advantages and cost-effectiveness.
    Lundkvist J; Ekman M; Ericsson SR; Jönsson B; Glimelius B
    Acta Oncol; 2005; 44(8):850-61. PubMed ID: 16332592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost analysis of radiotherapy, carbon ion therapy, proton therapy and BNCT in Japan.
    Nakagawa Y; Yoshihara H; Kageji T; Matsuoka R; Nakagawa Y
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S80-3. PubMed ID: 19394238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost evaluations of radiotherapy: What do we know? An ESTRO-HERO analysis.
    Defourny N; Dunscombe P; Perrier L; Grau C; Lievens Y
    Radiother Oncol; 2016 Dec; 121(3):468-474. PubMed ID: 28007378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Use of Crowdfunding to Support Radiation Therapy Cancer Treatments.
    Prabhu AV; Bimali M; Miljanic M; Kay H; Sandow L; Zhang M; Mumford K; Shah D; Clump DA; Skinner HD; Lewis GD
    Anticancer Res; 2021 Aug; 41(8):3759-3767. PubMed ID: 34281835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Particle therapy in clinical practice: is there enough evidence to justify the current surge in interest?
    Jalali R
    J Cancer Res Ther; 2008; 4(2):54-6. PubMed ID: 18688118
    [No Abstract]   [Full Text] [Related]  

  • 18. Point/counterpoint. Proton therapy is too expensive for the minimal potential improvements in outcome claimed.
    Schulz RJ; Smith AR; Orton CG
    Med Phys; 2007 Apr; 34(4):1135-8. PubMed ID: 17500444
    [No Abstract]   [Full Text] [Related]  

  • 19. [Which equipment for proton therapy of the future?].
    Schwartz LH; Laisne A; Ivanov AA; Mandrillon P; Chauvel P; Mazal A; Habrand JL; Tronc D; Baccal M; Laugier A
    Bull Cancer Radiother; 1995; 82(4):365-9. PubMed ID: 8554889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review of the cost and cost-effectiveness studies of proton radiotherapy.
    Verma V; Mishra MV; Mehta MP
    Cancer; 2016 May; 122(10):1483-501. PubMed ID: 26828647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.